1-3 of 3
Andrew J. Yee
Close
Sort by
Journal Articles

Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma

Clinical Trials & Observations
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Journal: Blood Advances
Blood Adv (2023) 7 (5): 768–777.
https://doi.org/10.1182/bloodadvances.2022007210
Published: 2023
Includes: Supplemental data
Journal Articles

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma

Elizabeth K. O’Donnell, Yael N. Shapiro, Andrew J. Yee, Omar Nadeem, Jacob P. Laubach, Andrew R. Branagan, Kenneth C. Anderson, Clifton C. Mo, Nikhil C. Munshi, Irene M. Ghobrial, Adam S. Sperling, Emerentia A. Agyemang, Jill N. Burke, Cynthia C. Harrington, Bonnie Y. Hu, Paul G. Richardson, Noopur S. Raje, Areej El-Jawahri
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4967–4974.
https://doi.org/10.1182/bloodadvances.2022007127
Published: 2022
Journal Articles

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study

Clinical Trials & Observations
Gareth P. Gregory, Shaji Kumar, Ding Wang, Daruka Mahadevan, Patricia Walker, Nina Wagner-Johnston, Carolina Escobar, Rajat Bannerji, Divaya Bhutani, Julie Chang, Francisco J. Hernandez-Ilizaliturri, Andreas Klein, John M. Pagel, Witold Rybka, Andrew J. Yee, Anne Mohrbacher, Mo Huang, Mohammed Farooqui, Patricia Marinello, Hang Quach
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1232–1242.
https://doi.org/10.1182/bloodadvances.2021005872
Published: 2022
Includes: Supplemental data